drugset / Trial / NCT02399657

Effect of Dexamethasone Implant in Hard Exudate Complicated With Diabetic Macular Edema

NCT02399657 ↗

Phase 4 Unknown 48 enrolled Inje University Allergan · collab
NaSingle-groupOpen-labelTreatment

Summary

A Single Arm, Single Dose Study to Evaluate the Effect of intravitreal dexamethasone implant (Ozurdex®) on hard exudates of diabetic macular edema.

Timeline

Start
2015-02
Primary completion
2016-12
Completion
2016-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.7 mg Intravitreal